The anticancer effects of artesunate (ART) have been well documented. However, its potential against skin cancer has not been explored yet. Herein we reported that 60 mu mol/l ART effectively inhibited A431 (human epidermoid carcinoma cells) growth but not that of HaCaT (normal human keratinocyte cells). Our results revealed that ART induced cell cycle arrest at G0/G1 phase through the downregulation of cyclin A1, cyclin B, cyclin D1, Cdk2, Cdk4, and Cdk6. This correlated with the upregulation of p21 and p27. The 5-bromodeoxyuridine incorporation assay also indicated that ART treatment reduced DNA synthesis in a time-dependent manner. Furthermore, ART induced mitochondrial apoptosis, as evidenced by annexin V/propidium iodide staining and w...
Background: The artemisinin derivative artesunate is effective in the treatment of severe malaria an...
Merkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer with frequent viral etiology...
International audienceMerkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer with f...
The artemisinin compounds, which are well-known for their potent therapeutic antimalarial activity, ...
Background: This study aims to determine the effects of artesunate on proliferation, apoptosis and β...
Cisplatin, which induces DNA damage, is standard chemotherapy for advanced bladder cancer (BCa). How...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Clinical and labo...
Artesunate, the active agent from Artemisia annua L. used in the traditional Chinese medicine, is be...
This study characterized the effects of artesunate on thyroid cancer and partially identified its re...
Novel therapeutic strategies are urgently needed for advanced metastatic prostate cancer (PCa). Phyt...
This report is designed to explore the exact molecular mechanism by which artesunate (ART), a semisy...
BACKGROUND: A major obstacle for successful cancer treatment often is the development of drug resist...
Breast cancer is the most common cancer and the second leading cause of cancer death in industrializ...
Artemisinin derivatives are well-tolerated anti-malaria drugs that also exert anti-cancer activity. ...
Breast cancer is the most common cancer and the second leading cause of cancer death in industrializ...
Background: The artemisinin derivative artesunate is effective in the treatment of severe malaria an...
Merkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer with frequent viral etiology...
International audienceMerkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer with f...
The artemisinin compounds, which are well-known for their potent therapeutic antimalarial activity, ...
Background: This study aims to determine the effects of artesunate on proliferation, apoptosis and β...
Cisplatin, which induces DNA damage, is standard chemotherapy for advanced bladder cancer (BCa). How...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Clinical and labo...
Artesunate, the active agent from Artemisia annua L. used in the traditional Chinese medicine, is be...
This study characterized the effects of artesunate on thyroid cancer and partially identified its re...
Novel therapeutic strategies are urgently needed for advanced metastatic prostate cancer (PCa). Phyt...
This report is designed to explore the exact molecular mechanism by which artesunate (ART), a semisy...
BACKGROUND: A major obstacle for successful cancer treatment often is the development of drug resist...
Breast cancer is the most common cancer and the second leading cause of cancer death in industrializ...
Artemisinin derivatives are well-tolerated anti-malaria drugs that also exert anti-cancer activity. ...
Breast cancer is the most common cancer and the second leading cause of cancer death in industrializ...
Background: The artemisinin derivative artesunate is effective in the treatment of severe malaria an...
Merkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer with frequent viral etiology...
International audienceMerkel cell carcinoma (MCC) is a rare and highly aggressive skin cancer with f...